Liposomes [156,167] |
Biocompatibility; can be loaded with both hydrophobic and hydrophilic compounds; low toxicity; can easily fuse with cell membrane |
Lack of long-term stability and ability to evade the host immune system |
Polymeric nanoparticles [156,167,168] |
Biocompatibility and biodegradability; higher stability; targeted drug delivery; nonimmunogenicity; low toxicity |
Toxic degradation, toxic monomers aggregation; difficult to scale-up |
Polymeric micelles [168] |
Controlled drug release; increased solubility of lipophilic compounds |
Low loading capacity; usable just for lipophilic drugs |
Carbon nanotubes [169] |
Ease of cellular uptake; high drug loading capacity; biocompatibility; specificity to cells, |
High toxicity, difficult to degrade |
Gold nanoparticles [170] |
Can be prepared in broad range of sizes, are easy to modify |
Biocompatibility and toxicity issues |
Solid lipid nanoparticles [167] |
Low cost; easy to scale-up; good physical stability; good tolerability |
Low drug loading; low controlability of drug release |
Dendrimers [168] |
Increased solubility of lipophilic compounds |
Toxicity; high cost of synthesis |
Extracellular vesicles |
Natural origin, biocompatibility, high stability, low toxicity, capacity to evade immune degradation, possible targeted delivery |
Presence of own cargo with possible diverse effects, lack of standardized isolation and loading methods |